When was Intelligencia founded?

Intelligencia was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Intelligencia located?

Intelligencia is headquartered in New York City, United States. It is registered at 180 VARICK STREET,6TH FLOOR,NEW YORK,NY,10014.

How many employees does Intelligencia have?

As of Aug 31, 2026, the latest employee count at Intelligencia is 110.

Is Intelligencia a funded company?

Intelligencia is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Aug 10, 2021.

When was the latest funding round of Intelligencia?

Intelligencia's latest funding was a $***** Series A round on Aug 10, 2021, with participation from 4 investors.

Where does Intelligencia rank among its competitors?

Intelligencia ranks 20th amongst 619 active competitors, of which 70 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was mPharma, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of Intelligencia?

Intelligencia's top competitors include Dedalus, Concert AI and Bioptimus. Among them, mPharma secured the most recent funding round in December, 2025.

Intelligencia - 2026 Company Profile, Team, Funding & Competitors

Company Details

Cloud and AI-led analytics platform for drug discovery and development. The company has developed iNsight a platform for analyzing structured and non-structured data to provide insights into clinical development decisions. The company provides solutions for the portfolio analysis of the potential risks of pre-market factors, ranging from the likelihood of asset failure in clinical trials to the likelihood of regulatory approval.

Website: www.intelligencia.ai/
Email ID: *****@intelligencia.ai
Phone Number: +1 **********
Registered Address: 180 VARICK STREET,6TH FLOOR,NEW YORK,NY,10014

Key Metrics

Founded Year

2018

Location

New York City, United States

Stage

Series A

Total Funding

$13.8M in 1 round

Latest Funding Round

Series A, Aug 10, 2021, $*****

Investors

MTIP & 6 more

Ranked

20^th among 619 active competitors

Employee Count

110 as on Aug 31, 2026

Similar Companies

Concert AI & 185 more

View Intelligencia's full profile

Intelligencia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Intelligencia Inc. CIN: 5374641 , United States, Active	Jul 12, 2018	-	-	-

Intelligencia has raised a total funding of $13.8M over 1 round. Its latest funding round was a Series A round on Aug 10, 2021 for $*****. 4 investors participated in its latest round. Intelligencia has 7 institutional investors.

Here is the list of recent funding rounds of Intelligencia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 10, 2021	2999445	Series A	7759390	9389207	6723722	7295340

Access funding benchmarks and valuations. Sign up today!

View details of Intelligencia's funding rounds and investors

The founders of Intelligencia are Vangelis Vergetis and Dimitrios Skaltsas.

Here are the details of Intelligencia's key team members:

Vangelis Vergetis: Co-Founder of Intelligencia and founder of 1 other company.
Contact Info: 2 email addresses
Dimitrios Skaltsas: Co-Founder of Intelligencia.
Contact Info: 1 email address

View details of Intelligencia's Founder profiles and Board Members

Intelligencia's employee count trend

Intelligencia has 110 employees as of Aug 26. Here is Intelligencia's employee count trend over the years:

Uncover Intelligencia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Intelligencia include Dedalus, Concert AI and Bioptimus. Here is the list of Top 10 competitors of Intelligencia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dedalus 1982, Milano (Italy), Acquired	Provider of advanced software solutions that enhance healthcare interoperability	$26.9M	ADIA, Tamburi Investment Partners & 8 others	64/100
2nd	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 4 others	64/100
3rd	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Sofinnova Partners, Cathay Innovation & 15 others	63/100
4th	Greenlight Guru 2013, Indianapolis (United States), Series A	Developer of quality management system software for the medical device industry	$121M	JMI Management, Elevate Ventures & 1 others	61/100
5th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	61/100
6th	mPharma 2013, Accra (Ghana), Series D	Provider of pharmacy management services and software for stock management for patients and pharmacies	$95.3M	Novastar Ventures, Citi & 33 others	60/100
7th	MasterControl 1994, Salt Lake City (United States), Late Stage	Developer of software for quality, manufacturing, and asset management solutions	$150M	Sixth Street, Sixth Street Growth	59/100
8th	Health Gorilla 2014, Coral Gables (United States), Series C	Provider of healthcare information network platform to access patient data	$80M	IA Capital Group, Nationwide & 14 others	58/100
9th	Rhapsody 2018, Boston (United States), Acquired	Interoperability solutions accelerating digital health through seamless data exchange and stronger connections	$13.2M	HgCapital Trust, Hg	57/100
10th	Qualio 2012, San Francisco (United States), Series B	Provider of cloud-based quality management software for the life science industry	$63.9M	500 Global, Storm Ventures & 10 others	57/100
20th	Intelligencia 2018, New York City (United States), Series A	Cloud and AI-led analytics platform for drug discovery and development	$13.8M	MTIP, By The Tower & 5 others	52/100